Latest Comments on Derek Lowe's Articles

1. Economyst on Drug Industry Spending: R&D vs. Marketing: Derek What about the effect on RnD of losing patents on... more »
2. BioBoy on Vanda Pharmaceuticals Comes Back from the Dead: The problem for Vanda owners is that even when Fanapt comes to... more »
3. PornNugget on Sanofi-Aventis's 'Voluntary' Staff Departures: ridiculous....just curious what other departments at GV had... more »
4. ZZZZ on Vanda Pharmaceuticals Comes Back from the Dead: I do know that they have brought back the VP of Sales as a... more »
5. teej on Sanofi-Aventis's 'Voluntary' Staff Departures: Well, those "voluntary" reductions fell particularly hard on staff... more »
6. DaveyD on Lilly's Free Compound Screening Will Draw Many Takers: Access Pharmaceuticals, a biotech company with many oncology... more »
7. you will be pleading the fifth on Elsevier Publicists Go Too Far: When I say "reviews" I am speaking of the official book... more »
8. you will be pleading the fifth on Elsevier Publicists Go Too Far: Not surprising at all. How do you think they get reviews? They... more »
9. in4thelonghaul on Is Medarex's Prostate Cancer Drug a Success? Too Early to Tell: You think maybe Dr. Kwon was cognizant of the unorthodox timing of... more »
10. kenny b on Is Medarex's Prostate Cancer Drug a Success? Too Early to Tell: Derek you should view this... more »
11. BBBB on A View from Pfizer's Corner Offices: As a Pfizer employee, I would say you are dead on. I wonder if we... more »
12. polar40 on Is Medarex's Prostate Cancer Drug a Success? Too Early to Tell: Biopharma is notorious for false signals which later prove to be... more »
13. kenny b on Is Medarex's Prostate Cancer Drug a Success? Too Early to Tell: From the MEDX MESSAGE BOARD regarding your article <more »
14. kenny b on Is Medarex's Prostate Cancer Drug a Success? Too Early to Tell: <more »
15. jq1234 on Is Medarex's Prostate Cancer Drug a Success? Too Early to Tell: I agree with user 435757, you should do more DD before writing... more »